Meskacel™ HPMC K100M
Product Description
Meska Joinway Pharmaceutical Co.,Ltd.
-
Country/Region:China
-
Founded:2003
-
On CPHI since:2023
-
Certificates:5
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
Meska Joinway Pharmaceutical Co.,Ltd.
-
Country/Region:China
-
Founded:2003
-
On CPHI since:2023
-
Certificates:5
-
Employees:250 - 499
Company types
Primary activities
More Products from Meska Joinway Pharmaceutical Co.,Ltd. (15)
-
Product Meskacel™ HPMC K4M
Meskacel™ HPMC K4M powder (Hydroxypropyl methylcellulose) is a nonionic cellulose ether and a high-viscosity modifier specially designed for the pharmaceutical industry. Meska Joinway, a Chinese HPMC supplier, sells HPMC K4M powder of excellent quality.
-
Product Meskacel™ HPMC K15M
Pharmaceutical-grade HPMC K15M powder is a nonionic cellulose ether, chemically modified from natural cellulose, and has excellent water solubility and adhesion. Its nominal viscosity is 15,000 mPa · s (2% aqueous solution, 20℃). -
Product Meskacel™ L-HPC LP11
Meskacel™ L-HPC LP11 powder (low-substituted hydroxypropyl cellulose) achieves efficient disintegration through capillary permeation and hydrogen bond breaking mechanism based on its low degree of substitution (≤11%) and porous microcrystalline structure. Its high porosity (≥60%) enables it ... -
Product Meskacel™ L-HPC LP22
Meskacel™ L-HPC LP22 power (Low-substituted hydroxypropyl cellulose LP22) is a high-performance pharmaceutical excipient. Its unique physicochemical properties make it a core disintegrant and filler for tablets, capsules, and sustained-release preparations. It is suitable for wet granulation, dry gran... -
Product Pharma Grade Hydroxypropyl Cellulose (HPC)
Meska Joinway's pharmaceutical-grade hydroxypropyl cellulose (HPC) is a high-purity, non-ionic, water-soluble cellulose ether derived from chemically modified natural cellulose. It exhibits excellent solubility in water and various polar organic solvents and offers multiple functional proper... -
Product Meskacel™ HPMC E5
Meskacel™ HPMC E5 powder (hydroxypropyl methylcellulose) is a nonionic cellulose ether, specially designed for rapid release preparations. Its core advantages include:
Low viscosity (5-10 mPa·s for 2% solution): Good fluidity, suitable for direct tablet pressing and wet granulation.
Rapid solubility:... -
Product Meskacel™ L-HPC LP21
As a nonionic polymer, L-HPC LP21 power has stable chemical properties, is not prone to chemical reactions with drugs, has little impact on the therapeutic effect of drugs, contains no peroxides, and cooperates well with oxygen-sensitive active drug components, ensuring the quality and stability ... -
Product Pharma Grade Methyl Cellulose (MC)
Methyl cellulose (MC) is a safe, stable pharmaceutical excipient. Meska Joinway produces high-quality MC that meets GMP standards for reliable, consistent products. Its products have the following functions:
· Increases the viscosity of the liquid, making the formulation more stable;
· Help... -
Product Meskacel™ HPMC E3
Meskacel™ HPMC E3 powder, pharmaceutical-grade hydroxypropyl methyl cellulose, has become an ideal choice in the pharmaceutical industry due to its outstanding performance and strict quality standards. The hydrophilic groups in its molecular structure endow it with properties such as thickening and adhesio... -
Product Meskacel™ HPMC E4
Meskacel™ HPMC E4 powder is a low-viscosity hydroxypropyl methyl cellulose semi-synthesised from natural plant cellulose. Its structure contains methoxy and hydroxypropyl groups, and presents different characteristics due to the differences in the content of substituents. It is stable in nat... -
Product Meskacel™ HPMC E6
Meskacel™ HPMC E6 powder (hydroxypropyl methyl cellulose) is a nonionic cellulose mixed ether, prepared from natural cotton fibres or wood pulp through a series of precise chemical treatments. The exquisite combination of methoxy and hydroxypropoxy groups in its chemical structure endows it ... -
Product Meskacel™ HPMC E15
Medical-grade Meskacel™ HPMC E15 powder is a low-viscosity hydroxypropyl methyl cellulose designed to meet various pharmaceutical excipient requirements. It is a white to slightly yellow fibrous or granular powder with a rich application history in the medical field.
Meska Joinway Pharmaceutical Co.,Ltd. resources (3)
-
Brochure MESKACEL PHARMACEUTICAL EXCIPIENTS-PRODUCT BROCHURE
Meska Joinwray Pharmaceutical Co., Ltd. has been a trusted manufacturer ofpharmaceutical excipients since its establishment in 2003,operating in fullcompliance with Good Manufacturing Practice (GMP') standards.wespecialize in praviding a comprehensive portfolio of cellulose ethers andhigh-performance excipients designed to optimize formulationdevelopment, imprave solubility, and enhance the delivery of activepharmaceutical ingredients.Since 2003,Meska Joinway has built a strong global presence, servingcustomers across multiple countries and fostering long-term,reliablepartnerships in the pharmaceutical industry.
-
Brochure MESKA JOINWAY PHARMACEUTICAL CO., LTD-PRODUCT BROCHURE
Meska Joinway Pharmaceutical Co., Ltd., established in 2003, specializes in the production and operation of a variety of new pharmaceutical-grade and industrial-grade cellulose ethers. Its pharmaceutical-grade cellulose related products are technologically leading in China. They are widely used in plant hollow capsules, film coating powders and related film-forming agents, sustained-release and controlled-release dosage form matrix materials, solid dosage form binders, stabilizers for ointments and emulsifiable concentrates, and thickening agents for lotions and gels.
-
Video Meska Joinway Pharmaceutical Co., Ltd - Corporate Video
Meska Joinway is a high-tech enterprise with over 20 years of experience in the production and sales of new pharmaceutical excipients and various industrial cellulose ethers. It is located in the provincial chemical industrial park of Linghu Town, Nanxun District, Huzhou City, China. The total investment in the construction of the factory area is $ 187 million, with a land area of approximately 94,000 square meters and an annual production capacity of 38,000 tons of cellulose ethers. The company has established a talent-driven pattern centered on innovation and R&D, with the proportion of professional and technical personnel dedicated to new product R&D exceeding 20%. Currently, research and development bases for new types of pharmaceutical excipients, pharmaceutical intermediates, preparations, and various industrial cellulose ethers have been established.











